Sponsor

Samsung Bioepis Co. Ltd.

76 Songdogyoyuk Ro, 21987

About the sponsor

Clinical research in non-small cell lung cancer includes studies in metastatic non-squamous disease and settings involving surgery and adjuvant treatment, with attention to treatment comparability against established PD-1 immunotherapy standards.

Metastatic non-squamous NSCLC
Early and locally advanced lung cancer
Immuno-oncology treatment comparison

The sponsor’s oncology portfolio is centered on therapies used in advanced and earlier-stage lung malignancies.

About Specializations

Samsung Bioepis Co. Ltd. runs clinical trials in conditions such as Macular oedema, Neovascular age-related macular degeneration, Choroidal neovascularisation, Non-small cell lung cancer, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Quick filters

2 clinical trials

Macular oedema+2

Not recruiting

Study on the Use of SB11 Pre-Filled Syringe for Patients with Wet Age-Related Macular Degeneration, Macular Edema from Retinal Vein Occlusion, or Myopic Choroidal Neovascularization

Registered drugNo placebo